Logo

ABVEW

Above Food Ingredients Inc. Warrants

ABVEW

Above Food Ingredients Inc. Warrants • NASDAQ
$0.85 ▲ 49.10% (+0.28)
Market Cap $419.63 M
52w High $1.45
52w Low $0.70
Dividend Yield 0%
P/E 0
Volume 374.02K
Outstanding Shares 493.69M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2024 $0 ▼ $774.124K ▼ $-32.617K ▲ 0% ▲ $-0.003 ▲ $-774.119K ▲
Q4-2023 $94.717M ▲ $12.753M ▲ $-22.649M ▼ -23.912% ▼ $-6.02 ▼ $-16.005M ▼
Q3-2023 $0 $668.98K ▼ $123.995K ▲ 0% $0.014 ▲ $-668.976K ▲
Q2-2023 $0 $1.586M ▲ $-742.433K ▲ 0% $-0.086 ▲ $-1.586M ▼
Q1-2023 $0 $1.235M $-1.012M 0% $-0.117 $-1.235M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2024 $5.809K ▲ $34.749M ▲ $5.963M ▲ $28.786M ▲
Q4-2023 $947 ▼ $30.922M ▼ $4.076M ▼ $-46.258M ▼
Q3-2023 $260.4K ▲ $160.561M ▲ $184.866M ▲ $-24.305M ▼
Q2-2023 $12.323K ▼ $41.215M ▼ $4.39M ▲ $36.825M ▼
Q1-2023 $53.287K $41.684M $3.328M $38.355M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2024 $-32.617K ▼ $-799.497K ▼ $7.738M ▲ $-6.934M ▼ $4.524K ▲ $-799.497K ▼
Q4-2023 $229.047K ▲ $-285.455K ▲ $-171K ▼ $456.681K ▲ $227 ▲ $-647.51K ▼
Q3-2023 $123.995K ▲ $-301.508K ▲ $1.435M ▲ $-1.145M ▼ $-11.622K ▲ $-301.508K ▲
Q2-2023 $-742.433K ▲ $-742.23K ▼ $-112.369K ▲ $814.729K ▲ $-39.87K ▲ $-742.23K ▼
Q1-2023 $-1.012M $-368.209K $-405.6K $710.079K $-63.73K $-368.209K

Five-Year Company Overview

Income Statement

Income Statement Above Food is still a very small, early-stage business with only modest sales and recurring losses. Revenue has grown from almost nothing to a small base, but costs still outweigh income, leading to negative operating profit and net losses each year. Profitability has not yet been established, and recent years show earnings per share moving deeper into the red, which suggests dilution risk and that the business model is still being built out rather than optimized for profit. Overall, the income statement looks like that of a company in heavy build‑out mode, not yet close to steady, sustainable earnings.

Balance Sheet

Balance Sheet The balance sheet is thin and fragile. The company operates with a very small asset base, very limited cash on hand, and a noticeable amount of debt relative to its size. Equity has recently turned negative, which is a warning sign that accumulated losses have eroded the capital base. This points to financial vulnerability: the company appears dependent on ongoing access to lenders or new equity capital and has little cushion if things do not go as planned. In simple terms, it has big ambitions but a very light balance sheet to support them.

Cash Flow

Cash Flow Cash generation from operations has been minimal and inconsistent, reflecting the small scale and continuing losses. Investment spending has been limited in recent periods, but earlier years show cash going out for development and capacity. With no evident internal cash engine, the company seems reliant on external funding to support operations and growth. Overall, the cash flow profile is what you would expect from an early-stage, capital‑hungry business that has not yet proven it can fund itself from its own activities.

Competitive Edge

Competitive Edge On the food side, Above Food is trying to build a differentiated position with a fully integrated “seed‑to‑fork” model: control of seed genetics, farming practices, processing, and even consumer brands. Its use of regenerative agriculture, strong traceability, and proprietary plant‑based ingredients gives it a story that stands apart from generic commodity players. The acquisition of assets in specialty crops and pet food ingredients further deepens that niche. However, the company is still small compared with global food majors, so its bargaining power and brand recognition remain limited. The planned expansion into fintech and asset tokenization is unusual in this sector and, if executed well, could create a distinct hybrid positioning—but it also adds complexity and execution risk, as the company will be competing in two very different, highly competitive arenas.

Innovation and R&D

Innovation and R&D Innovation is clearly a core theme. Above Food is investing in AI‑driven seed genomics, proprietary crop varieties, and processing methods that aim to protect nutrition and functionality. Its “grow‑to‑order” concept, where genetics and farming are tailored to specific customer needs, is a forward‑looking idea that could support premium pricing and long‑term relationships if it scales. The company has also acquired substantial intellectual property and is pursuing tokenization of agricultural and environmental assets, as well as stablecoin and digital currency infrastructure in partnership with sovereign entities. This is a highly ambitious blend of agri‑tech and fintech innovation. The upside is meaningful differentiation; the downside is substantial technology, regulatory, and integration risk across very different domains.

Summary

Overall, Above Food looks like an ambitious but financially fragile company in transition. The core food business is still small and loss‑making, with a light balance sheet and limited internal cash generation, which increases dependence on outside financing. Strategically, it is trying to build a defensible, vertically integrated platform in regenerative, plant‑based foods while simultaneously pivoting into digital assets, tokenization, and stablecoins through the Palm Global transaction. This creates a potentially unique “agritech‑to‑fintech” story, but also layers on complexity, regulatory exposure, and high execution risk. For warrant holders, it is especially important to recognize that outcomes depend heavily on the company’s ability to both scale its underlying food operations and successfully execute its new fintech strategy from a relatively weak financial starting point.